A. A. Gershon

1.4k total citations
19 papers, 1.1k citations indexed

About

A. A. Gershon is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, A. A. Gershon has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in A. A. Gershon's work include Herpesvirus Infections and Treatments (17 papers), Toxin Mechanisms and Immunotoxins (5 papers) and Animal Virus Infections Studies (4 papers). A. A. Gershon is often cited by papers focused on Herpesvirus Infections and Treatments (17 papers), Toxin Mechanisms and Immunotoxins (5 papers) and Animal Virus Infections Studies (4 papers). A. A. Gershon collaborates with scholars based in United States, Israel and France. A. A. Gershon's co-authors include Michael D. Gershon, Zhenglun Zhu, Richard T. Ambron, Christopher A. Gabel, Sharon P. Steinberg, Sharon Steinberg, Octavian Lungu, Saul J. Silverstein, Philip LaRussa and Diane L. Sherman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neurology and Clinical Infectious Diseases.

In The Last Decade

A. A. Gershon

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. A. Gershon United States 16 995 224 210 208 204 19 1.1k
Abbas Vafai United States 19 1.2k 1.2× 263 1.2× 292 1.4× 180 0.9× 236 1.2× 49 1.4k
Catherine Sadzot‐Delvaux Belgium 25 1.4k 1.4× 323 1.4× 257 1.2× 274 1.3× 260 1.3× 52 1.6k
S. Debrus Belgium 18 650 0.7× 188 0.8× 195 0.9× 141 0.7× 108 0.5× 31 962
Vicki Traina‐Dorge United States 20 683 0.7× 348 1.6× 128 0.6× 268 1.3× 178 0.9× 53 1.3k
H. J. Field United Kingdom 14 843 0.8× 128 0.6× 56 0.3× 276 1.3× 64 0.3× 19 957
Charles Wohlenberg United States 16 850 0.9× 228 1.0× 89 0.4× 325 1.6× 44 0.2× 22 1.2k
A. Buchan United Kingdom 20 904 0.9× 164 0.7× 109 0.5× 301 1.4× 44 0.2× 56 1.2k
Jeffery L. Meier United States 26 1.3k 1.3× 248 1.1× 101 0.5× 336 1.6× 305 1.5× 55 1.7k
Magdalena Kosz‐Vnenchak Poland 15 1.1k 1.1× 221 1.0× 89 0.4× 431 2.1× 44 0.2× 36 1.4k
Fiona E. Jamieson United Kingdom 7 854 0.9× 150 0.7× 78 0.4× 219 1.1× 131 0.6× 8 948

Countries citing papers authored by A. A. Gershon

Since Specialization
Citations

This map shows the geographic impact of A. A. Gershon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. A. Gershon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. A. Gershon more than expected).

Fields of papers citing papers by A. A. Gershon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. A. Gershon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. A. Gershon. The network helps show where A. A. Gershon may publish in the future.

Co-authorship network of co-authors of A. A. Gershon

This figure shows the co-authorship network connecting the top 25 collaborators of A. A. Gershon. A scholar is included among the top collaborators of A. A. Gershon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. A. Gershon. A. A. Gershon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gershon, A. A., Gillian Kay, Merav Hecht, et al.. (2024). DNMT3B splicing dysregulation mediated by SMCHD1 loss contributes to DUX4 overexpression and FSHD pathogenesis. Science Advances. 10(22). eadn7732–eadn7732. 3 indexed citations
2.
Hambleton, Sophie, Sharon P. Steinberg, Michael D. Gershon, & A. A. Gershon. (2007). Cholesterol Dependence of Varicella-Zoster Virion Entry into Target Cells. Journal of Virology. 81(14). 7548–7558. 59 indexed citations
3.
4.
Hambleton, Sophie, Michael D. Gershon, & A. A. Gershon. (2004). The role of the trans-Golgi network in varicella zoster virus biology. Cellular and Molecular Life Sciences. 61(24). 3047–3056. 27 indexed citations
5.
Gershon, Michael D. & A. A. Gershon. (1999). Role of Glycoproteins in Varicella-Zoster Virus Infection. PubMed. 3. 43–60. 11 indexed citations
6.
Wang, Z., Michael D. Gershon, Octavian Lungu, et al.. (1998). Intracellular Transport of Varicella‐Zoster Glycoproteins. The Journal of Infectious Diseases. 178(s1). S7–S12. 21 indexed citations
7.
Zhu, Zhenglun, Michael D. Gershon, Christopher A. Gabel, et al.. (1995). Entry and egress of varicella-zoster virus. Neurology. 45(12_suppl_8). S15–7. 37 indexed citations
8.
Zhu, Zhenglun, Michael D. Gershon, Yao Hao, et al.. (1995). Envelopment of varicella-zoster virus: targeting of viral glycoproteins to the trans-Golgi network. Journal of Virology. 69(12). 7951–7959. 95 indexed citations
9.
Lungu, Octavian, Paula W. Annunziato, A. A. Gershon, et al.. (1995). Reactivated and latent varicella-zoster virus in human dorsal root ganglia.. Proceedings of the National Academy of Sciences. 92(24). 10980–10984. 120 indexed citations
10.
Zhu, Zhenglun, Michael D. Gershon, Richard T. Ambron, Christopher A. Gabel, & A. A. Gershon. (1995). Infection of cells by varicella zoster virus: inhibition of viral entry by mannose 6-phosphate and heparin.. Proceedings of the National Academy of Sciences. 92(8). 3546–3550. 89 indexed citations
11.
Gershon, A. A., Diane L. Sherman, Zhenglun Zhu, et al.. (1994). Intracellular transport of newly synthesized varicella-zoster virus: final envelopment in the trans-Golgi network. Journal of Virology. 68(10). 6372–6390. 180 indexed citations
12.
LaRussa, Philip, Octavian Lungu, Iain R. B. Hardy, et al.. (1992). Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. Journal of Virology. 66(2). 1016–1020. 173 indexed citations
13.
LaRussa, Philip, et al.. (1985). Determination of Immunity to Varicella-Zoster Virus by Means of an Intradermal Skin Test. The Journal of Infectious Diseases. 152(5). 869–875. 37 indexed citations
14.
Gershon, A. A.. (1985). Live Attenuated Varicella Vaccine. The Journal of Infectious Diseases. 152(5). 859–862. 24 indexed citations
15.
Gershon, A. A.. (1980). Live Attenuated Varicella-Zoster Vaccine. Clinical Infectious Diseases. 2(3). 393–407. 30 indexed citations
16.
Steinberg, Sharon, et al.. (1977). Immune Adherence Hemagglutination: Further Observations on Demonstration of Antibody to Varicella-Zoster Virus. The Journal of Infectious Diseases. 135(6). 1010–1013. 20 indexed citations
17.
Gershon, A. A., et al.. (1976). Detection of Antibody to Varicella-Zoster Virus by Immune Adherence Hemagglutination. Experimental Biology and Medicine. 151(4). 762–765. 69 indexed citations
18.
Brunell, P. A., A. A. Gershon, S.A. Uduman, & Sharon Steinberg. (1975). Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster. The Journal of Infectious Diseases. 132(1). 49–54. 80 indexed citations
19.
Gershon, A. A., et al.. (1973). Observations on the Growth of Varicella-Zoster Virus in Human Diploid Cells. Journal of General Virology. 18(1). 21–31. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abbas Vafai Breakdown of academic impact, for papers by Catherine Sadzot‐Delvaux Breakdown of academic impact, for papers by S. Debrus Breakdown of academic impact, for papers by Vicki Traina‐Dorge Breakdown of academic impact, for papers by H. J. Field Breakdown of academic impact, for papers by Charles Wohlenberg Breakdown of academic impact, for papers by A. Buchan Breakdown of academic impact, for papers by Jeffery L. Meier Breakdown of academic impact, for papers by Magdalena Kosz‐Vnenchak Breakdown of academic impact, for papers by Fiona E. Jamieson
Rankless by CCL
2026